Solstice Group, operating under the slogan "From marijuana to cannabis," is an established player in the cannabis industry since 2011, with its operations rooted in Seattle, Washington. The company has made significant strides as the pioneering commercial supplier of medical cannabis in Washington State and was a trailblazer in setting up the first fully permitted cannabis production facility back in 2012.
The enterprise specializes in producing and processing high-quality cannabis and related products, delivering them to medical cannabis retail outlets. With expertise spanning the Agriculture and Manufacturing industries, Solstice Group is strategically positioned within the burgeoning U.S. cannabis market.
The company's latest financial milestone was an $8.00M Series A investment closed on 12 March 2020. This influx of capital underscores investor confidence and positions Solstice Group favorably for further growth and expansion. Despite no named investors, the Series A funding reflects strong backing and potential for scaling operations.